Pr3vent Inc., founded with the mission to protect and enhance infant vision, is a US-based AI healthcare company specializing in machine learning screens for newborn ophthalmic conditions. The company's core vision is to ensure better vision and a brighter future for infants through advanced newborn vision screening. Pr3vent offers professional imaging and expert evaluation services that screen more of the eye, enabling early detection and protection of infant vision. Their market focus is on healthcare providers and parents in the United States who seek proactive measures for their newborns' eye health.

Notable affiliated people and investors include leading experts in ophthalmology and artificial intelligence, though specific names are not provided. Key achievements of Pr3vent include the development and deployment of advanced AI-driven screening tools that have significantly improved early detection rates of ophthalmic conditions in newborns. The overall impact of Pr3vent has been substantial, providing peace of mind to parents and facilitating early interventions that can prevent long-term vision problems in children.